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– ELBW infants (birth weight < 1kg) 
– Informed parental consent 
 
FGF10 SNPs Analysis: 
 DNA was isolated from buccal swabs and real-time 
PCR was performed using Taqman probes 
 
BPD is defined by the need for oxygen 
supplementation at 36 weeks post menstrual age.  
Statistics: Student’s t-test, Chi-square, Mann-Whitney, 
z-test; P <0.05  
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   PDA  No PDA p-value 
   GA (wk; median;IQR) 25 (24, 26) 25 (24, 26) 0.1 
 BW (gm; mean± SD) 742±171  737 ±175 0.9 
Prenatal Steroid 52(78%) 17 (74%) 0.8 
Female Gender 32(49%) 12(50%) 0.6 
Race 
Non Hispanic White 17(29%) 9(28%) 
0.6 
Non Hispanic Black 15(26%) 11(34%) 
Hispanic 22(38%) 11(34%) 
Other 4(7%) 1(3%) 
FGF10 SNP ; rs2973644, rs900379, rs1011814 
are associated with susceptibility to PDA and 
or BPD in ELBW infants. 
Demographic Characteristics- PDA 
FGF10 signaling pathway 
Genotype Distribution-BPD 













Wild allele 19(58%) 22(49%) 17(45%) 25(47%) 15(50%) 20(37%) 
Heterozygous 7(21%) 14(31%) 12(31%) 20(37%) 7(24%) 15(28%) 
Minor allele 7(21%)  9(20%) 9(24%) 8(15%) 8(26%) 19(35%) 
Any variant allele 14(42%) 23(51%) 21(55%) 28(52%) 15(50%) 34(63%) 
FGF10 expression and lung bud 
morphogenesis 
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Roles of FGF 10 – 
Fibroblast growth factor 10 (FGF10) plays a 
significant role in cardiac outflow tract 
formation and possible PDA. Downregulation of 
the FGF/Ras/Erk pathway are important for the 
differentiation of the progenitors and 
colonization of the cardiac outflow tract.  
FGF10 is also an integral part of the signaling 
required for distal lung branching 
morphogenesis in fetus. It is an alveolar 
epithelium cell (AEC) mitogen protects against 
cyclic stretch and oxidant injury via DNA repair. 
It regulates the mitogen activated protein kinase 
pathway (MAPK) that, in turn activates the Na-K-
ATPase in AEC - protein responsible for fetal 
lung fluid resorption and β2 receptor mediated 
actions.  
FGF10 SNPs ; rs2973644, rs900379, rs1011814 
were chosen as the SNPs were studied in adult  
collagen disorders. 
Patent Ductus Arteriosus 
Persistent PDA is defined as requiring medical 
treatment/surgery 
It causes significant morbidity in the ELBW 
infants 
Bronchopulmonary Dysplasia 
Defined as an oxygen need at 36 weeks 
postmenstrual age 
Incidence is about 40% for ELBW infants 
Genetic variation may predispose to BPD in 
preterm infants about 30-80% 
 
•Low birth weight and gestational age  was associated with 
BPD 
•FGF10 SNP ; rs2973644, rs900379, rs1011814 were not 
associated with PDA and or BPD. 
• Other SNPS may be involved in the susceptibility of PDA or 
BPD 













Wild allele  9(31%) 7(14%) 15(48%) 26(45%) 10(33%) 25(45%) 
Heterozygous 6(20%) 14(28%) 9(29%) 22(38%) 6(20%) 15(27%) 
Minor allele 14(48%) 28(57%) 7(22%) 9(15%) 14(47%) 16(28%) 
 Any variant 
allele 20(68%) 42(85%) 16(51%) 31(53%) 20(67%) 31(55%) 
Genotype Distribution -PDA 
α: p<0.05   β: NS 
 
















    Shh AEC 
*Alveolar epithelial cell, fibroblast growth factor 10, extracellular signal 
regulated kinase, Guanosine triphosphate, Sonic hedgehog, Growth factor 
receptor-bound protein 2 , Son of sevenless, mitogen extracellular kinase   
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  No BPD  BPD p-value 
   GA (wk; median;IQR) 26 (25, 27) 25 (24, 26) 0.001 
 BW (gm; mean± SD) 761±143  690 ±157  0.001 





Female Gender 18(60%) 24(45%) 0.1 
Race 
Non Hispanic White 9(30%) 11(19%) 
0.4 
Non Hispanic Black 5(16%) 16(28%) 
Hispanic 11(37%) 13(23%) 
Other 5(16%) 13(23%) 
Methods 
Demographic Characteristics- BPD 
Conclusions References 
